Clinical Study "Common" Name (formal title)	Number of enrollees	Funding source (pharma/NIH)	Year complete	Primary publication	Full study treatment protocol
CRUISE (Ranibizumab for the Treatment of Macular Edema after Central Retinal Vein OcclUsIon Study: Evaluation of Efficacy and Safety)	392	Genentech	2010/2011	Brown DM, Campochiaro PA, Singh RP, et al. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. Ophthalmology. 2010;117:1124-1133.e1. https://www.aaojournal.org/article/S0161-6420(10)00186-7/fulltext Campochiaro PA, Brown DM, Awh CC, et al. Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study. Ophthalmology. 2011;118:2041-9. https://www.aaojournal.org/article/S0161-6420(11)00224-7/fulltext